Inhalation Anesthesia Market Growth, Share, Industry Size and Forecast 2023-2028

Comments · 41 Views

The global inhalation anesthesia market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.

IMARC Group, a leading market research company, has recently released a report titled “Inhalation Anesthesia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global inhalation anesthesia market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What Are The Growth Prospects Of The Inhalation Anesthesia Industry?

According to the report, The global inhalation anesthesia market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.9 Billion by 2028, exhibiting a growth rate (CAGR) of 3.4% during 2023-2028.

What is Inhalation Anesthesia?

Inhalation anesthesia refers to the medication that is induced to maintain the general anesthesia and sedation level in the body during surgery. It does not accumulate in the body and helps prevent excessive dosage while promoting the normal functioning of the patient. Inhalation anesthetic agents with low pungency and non-irritant odor are widely used in hospitals and other ambulatory healthcare centers for patients with asthma or sensitive air passages.

Request for a free sample copy of this report:

What are the growth prospects and trends in the Inhalation Anesthesia industry?

The global inhalation anesthesia market is primarily driven by the growing aging population, which is more susceptible to cardiovascular, neurological, respiratory and degenerative disorders. Besides this, the increasing number of surgical procedures has also led to an escalated demand for inhalation anesthesia, which has a lower risk of delirium and is cost-effective than intravenous anesthesia(IVA). Furthermore, the development of anesthesia recycling systems for extracting anesthetic compounds from hospital vents and operating rooms is also contributing to the market growth. Some of the other factors, such as the introduction of variants with enhanced compatibility and minimal side-effects, improvements in the healthcare sector and extensive research and development (RD) activities, provide positive growth to the market.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Others

Breakup by Application:

  • Induction
  • Maintenance

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbvie Inc.
  • Baxter International Inc.
  • Fresenius SE Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Ltd.
  • Troikaa Pharmaceuticals Ltd.

Ask Analyst for Free Sample Report:

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US



USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal

Read more